Athira Pharma, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.74 | -$0.74 | -$0.74 |
Q2 2024 | 2 | -$0.70 | -$0.70 | -$0.70 |
Q3 2024 | 0 | -$0.51 | -$0.51 | -$0.51 |
Q1 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
Q2 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
Q3 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
Q4 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
Athira Pharma, Inc. Earnings Date And Information
Athira Pharma, Inc. last posted its earnings results on Thursday, August 1st, 2024. The company reported $-0.7 earnings per share for the quarter, topping analysts' consensus estimates of $-0.75 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Athira Pharma, Inc. has generated $-3 earnings per share over the last year ($-3.09 diluted earnings per share) and currently has a price-to-earnings ratio of -0.15. Athira Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Athira Pharma, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/09/2024 | Q2 2024 | -$0.70 | $0 | $0 | ||
05/15/2024 | Q1 2024 | -$0.80 | -$0.69 | 0.11 | $0 | |
02/22/2024 | Q4 2023 | -$0.96 | -$0.72 | 0.24 | $1.66 M | |
11/09/2023 | Q3 2023 | -$0.87 | -$0.87 | 0 | $0 | |
08/10/2023 | Q2 2023 | -$0.81 | -$0.78 | 0.03 | $0 | |
05/11/2023 | Q1 2023 | -$0.66 | -$0.68 | -0.02 | $0 | |
03/23/2023 | Q4 2022 | -$0.70 | -$0.68 | 0.02 | $0 | |
11/10/2022 | Q3 2022 | -$0.67 | -$0.43 | 0.24 | $0 | |
08/15/2022 | Q2 2022 | -$0.66 | -$0.65 | 0.01 | $0 | |
05/12/2022 | Q1 2022 | -$0.63 | -$0.49 | 0.14 | $0 | |
03/28/2022 | Q4 2021 | -$0.44 | $0 | |||
11/10/2021 | Q3 2021 | -$0.50 | -$0.42 | 0.08 | $0 | |
08/16/2021 | Q2 2021 | -$0.37 | -$0.38 | -0.01 | $0 | |
05/13/2021 | Q1 2021 | -$0.30 | -$0.25 | 0.05 | $0 | |
03/25/2021 | Q4 2020 | -$0.29 | -$0.22 | 0.07 | $0 | |
11/12/2020 | Q3 2020 | -$0.25 | -$1.12 | -0.87 | $100,000 | $0 |
06/29/2020 | Q2 2020 | -$0.07 | $0 | |||
03/30/2020 | Q1 2020 | -$0.21 | $0 | |||
12/30/2019 | Q4 2019 | -$0.11 | $0 | |||
09/29/2019 | Q3 2019 | -$0.18 | $0 |
Athira Pharma, Inc. Earnings: Frequently Asked Questions
-
When is Athira Pharma, Inc.'s earnings date?
Athira Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
Did Athira Pharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, Athira Pharma, Inc. (:ATHA) reported $-0.7 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.75 by $0.05.
-
How can I listen to Athira Pharma, Inc.'s earnings conference call?
The conference call for Athira Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Athira Pharma, Inc.'s conference call transcript?
The conference call transcript for Athira Pharma, Inc.'s latest earnings report can be read online.
-
How much profit does Athira Pharma, Inc. generate each year?
Athira Pharma, Inc. (:ATHA) has a recorded net income of $0. Athira Pharma, Inc. has generated $-3.09 earnings per share over the last four quarters.
-
What is Athira Pharma, Inc.'s price-to-earnings ratio?
Athira Pharma, Inc. (:ATHA) has a price-to-earnings ratio of -0.15 and price/earnings-to-growth ratio is 0.